Literature DB >> 31674304

Global Surveillance of trans-Fatty Acids.

Chaoyang Li1, Laura K Cobb2, Hubert W Vesper3, Samira Asma4.   

Abstract

Trans-fatty acid (TFA) intake can increase the risk of coronary heart disease (CHD) morbidity and mortality and all-cause mortality. Industrially produced TFAs and ruminant TFAs are the major sources in foods. TFA intake and TFA-attributed CHD mortality vary widely worldwide. Excessive TFA intake is a health threat in high-income countries; however, it is also a threat in low- and middle-income countries (LMICs). Data on TFA intake are scarce in many LMICs and an urgent need exists to monitor TFAs globally. We reviewed global TFA intake and TFA-attributed CHD mortality and current progress toward policy or regulation on elimination of industrially produced TFAs in foods worldwide. Human biological tissues can be used as biomarkers of TFAs because they reflect actual intake from various foods. Measuring blood TFA levels is a direct and reliable method to quantify TFA intake.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31674304      PMCID: PMC6880923          DOI: 10.5888/pcd16.190121

Source DB:  PubMed          Journal:  Prev Chronic Dis        ISSN: 1545-1151            Impact factor:   2.830


What is already known on this topic?

Trans-fatty acid (TFA) intake increases the risk of morbidity and mortality due to coronary heart disease and all-cause mortality. Many low- and middle-income countries lack accurate and reliable data on TFA intake in their populations.

What is added by this report?

We found wide variations in global burden of TFA intake. TFA intake and TFA-attributed cardiovascular disease has decreased in high-income countries. An urgent need exists to measure and monitor TFA intake globally. Human biological tissues can be used as biomarkers of TFAs as they reflect actual intake from various foods.

What are the implications for public health practice?

Laboratory testing of TFA levels in plasma or serum is a direct and reliable method for estimating short-term TFA intake from foods. Measuring and monitoring TFA intake in the population is key for making evidence-based policies and evaluating the effectiveness of public health interventions.

Background

The World Health Organization (WHO) calls for elimination of industrially produced (artificial) trans-fatty acids (TFAs) from the global food supply by 2023; in May 2018 WHO launched the REPLACE (review, promote, legislate, assess, create, enforce) action package to provide strategic guidance for all countries to take action toward this goal (1). One of the 6 components of the REPLACE package is to “assess and monitor trans-fats content in the food supply and changes in trans-fat consumption in the population.” Measuring the TFA levels in human biologic tissues can be an objective and reliable method for quantifying total TFA intake from foods (2–4). TFAs are derived from 2 major sources: industrially produced TFAs (iTFAs) and ruminant TFAs (rTFAs). Partially hydrogenated oils are the primary sources of iTFAs and are found in margarines, shortenings, baked goods, some popular processed and frozen foods (microwave popcorn, frozen pizza, snack foods), and fried foods (5). Dairy products and meats of ruminant animals (eg, cattle, sheep, goats) may contain small quantities of rTFAs. Both iTFAs and rTFAs consist of the same positional trans isomers, but they differ in distribution and amount. The number of calories in iTFAs as a proportion of the number of calories in all TFAs in the daily diet varies across countries; this proportion is estimated to range from 20% to 80% (5). In practice, because it is difficult to distinguish between iTFAs and rTFAs in human biologic tissues, total TFAs are quantified. Evidence from experimental studies, dietary trials, and prospective observational studies in which TFAs are measured by biomarkers or dietary records consistently shows that intake of TFAs, from either industrial or natural sources, can increase low-density lipoprotein (“bad”) cholesterol levels, decrease high-density lipoprotein (“good”) cholesterol levels, and is associated with an increased risk of coronary heart disease (CHD) morbidity and mortality and all-cause mortality (6,7). Daily intake of total TFAs varies worldwide; the estimated contribution to total energy intake ranges from 0.2% in Barbados to 6.5% in Egypt. Even small amounts of TFAs can contribute to increased risk of CHD (8). Every year, more than a half-million deaths from CHD worldwide may be attributable to high intake of TFAs (defined by Wang et al [8] as >0.5% of total energy intake); most of these deaths occur in low- and middle-income countries (LMICs) (8). Based on data published by the Global Burden of Diseases Nutrition and Chronic Diseases Expert Group (8) and application of the Pareto principle (9), 15 countries account for approximately 80% of the total number of CHD deaths attributable to high intake of TFAs globally (Figure 1).
Figure 1

Pareto analysis on the estimated number of deaths from coronary heart disease attributable to high intake of trans-fatty acids (TFAs) (defined by Wang et al [8] as >0.5% of total energy intake), top 30 countries. Pareto charts are used to describe the countries in descending order of the total estimated number of CHD deaths worldwide (9). In this chart, bars indicate the estimated number of CHD deaths attributable to high TFA intake, the curved line indicates cumulative percentages, and the dashed line indicates the 15 countries that account for 80% of total CHD deaths attributable to high TFA intake worldwide according to the Pareto principle (the 80/20 rule). Data source: Wang et al (8).

Pareto analysis on the estimated number of deaths from coronary heart disease attributable to high intake of trans-fatty acids (TFAs) (defined by Wang et al [8] as >0.5% of total energy intake), top 30 countries. Pareto charts are used to describe the countries in descending order of the total estimated number of CHD deaths worldwide (9). In this chart, bars indicate the estimated number of CHD deaths attributable to high TFA intake, the curved line indicates cumulative percentages, and the dashed line indicates the 15 countries that account for 80% of total CHD deaths attributable to high TFA intake worldwide according to the Pareto principle (the 80/20 rule). Data source: Wang et al (8).

Progress Toward Reduction of TFA Intake

The harmful health effects of TFAs, combined with high levels of iTFA intake, have motivated policy makers in many countries to take action. In the past 15 years, progress has been made toward reducing iTFA intake (10–13). In 2003, Denmark was the first country to enact a law to restrict the iTFA content of all food products and ready-to-eat meals, requiring that no more than 2% of the total fat content could come from iTFAs (10). Canada and the United States, where the daily dietary intakes of TFAs were more than twice the WHO-recommended limit of 1% of energy intake (5), were among the first countries to introduce mandatory labeling of TFAs in packaged foods in 2003; mandatory labeling went into effect in Canada in 2005 and the United States in 2006 (11,12). In the absence of national restrictions, numerous local jurisdictions in the United States, such as New York City, restricted TFAs in food service establishments, including restaurants, caterers, mobile food-vending units, and mobile food commissaries (13). In recent years, both the United States and Canada used existing food additive regulations to issue determinations that partially hydrogenated oils are not generally recognized as safe for any use in human foods, becoming the first countries to effectively ban iTFAs (11,12). To date, some 40 countries, most of which are high-income or upper-middle–income countries, have adopted mandatory restriction of iTFAs, banned the use of partially hydrogenated oils, and/or required mandatory labeling of TFAs on packaged foods (Figure 2).
Figure 2

Countries with policies or regulations on industrially produced (artificial) TFAs. Data source: World Health Organization (14). Abbreviation: PHO, partially hydrogenated oil; TFA, trans-fatty acid.

Countries with policies or regulations on industrially produced (artificial) TFAs. Data source: World Health Organization (14). Abbreviation: PHO, partially hydrogenated oil; TFA, trans-fatty acid. Reductions in TFA intake, iTFAs in foods, and TFA-attributed CHD mortality have been reported in the United States, Denmark, and Argentina since the implementation of TFA policies (13,15–20). In the United States overall, from 1999–2000 to 2009–2010, plasma TFA levels decreased by 54% in adults aged 20 or older (15); both TFA food labeling and local regulations were enacted during this 10-year period. New York City’s 2007 regulation restricting TFAs in food-service establishments was associated with a significant reduction of 2.4 g in mean TFAs in fast-food purchases (13) and a greater decline in adult serum TFA levels among frequent restaurant diners (61.6%) than among people who rarely dined out (51.1%) (16). These declines show how the effect of the regulation in New York City added to the effect of labeling overall in the United States (16). Cardiovascular disease mortality was also affected, declining by 4.5% in New York City (17) and by 22 deaths per 100,000 person-year in Denmark (18). Restaurant restrictions in 11 counties in New York State were associated with an additional 6.2% decline, compared with 25 counties without TFA restrictions, in the hospital admission rate for myocardial infarction and stroke (19). Similarly, near elimination of iTFAs in Argentina was associated with a 1.3% to 6.3% reduction in CHD events in 2004 and 2014 (20). Elimination of iTFAs from the food supply is politically viable, economically favorable, and technically feasible. Successful experiences in high-income countries such as the United States and Denmark can be transferred to LMICs. Some LMICs, such as Argentina, Brazil, Costa Rica, India, and Mexico, have taken steps to enact policies and/or create surveillance systems for monitoring TFA content in cooking oils and foods (21). However, most LMICs have no policies on iTFAs or have not enforced the policies they do have, despite the growing burden of CHD. Making the case to restrict TFAs through regulation or legislation requires more than just the scientific case against TFAs. Information on the level of iTFAs in foods or on TFA intake are critical to motivate stakeholders and to evaluate the progress of eliminating partially hydrogenated oils in the food supply. To date, however, little is known about TFA intake in most LMICs (5), let alone the potential reduction in CHD burden and health benefits that could result from the elimination of iTFAs. For example, removal of partially hydrogenated oils in the United States was estimated to save $130 billion over 20 years and prevent 3,000 to 7,000 deaths due to CHD annually (12).

Implications for Public Health Practice

Need for objective and accurate measurement of TFA intake worldwide

In light of gaps in data on TFA intake, there is an urgent need to measure and monitor TFA intake globally. The current methods for estimating TFA intake are difficult to implement in LMICs. The primary method for estimating TFA intake is to collect data through food frequency dietary interviews in national health and nutrition surveys. In these surveys, the quantity of food products consumed is examined, and the TFA content is analyzed by consulting nutrition databases. Limitations of this method include incomplete or nonexistent information on TFA content in various food products and the reliance of dietary questionnaires on participant recall. Although it is possible to test popular foods for their TFA content, this testing is complex because TFA content may vary across brand (or vendor) and by geographic region. Furthermore, if countries are not already sampling and testing foods for other nutrients, new surveys would need to be developed and implemented. A second common method for estimating TFA intake is to survey a small sample of people and test duplicate portions of their meals for TFAs; this method is costly and complicated. A fast and effective approach for assessing the effect of policies is to measure TFA levels in blood. Such data are not currently available in many countries. The Centers for Disease Control and Prevention (CDC) pioneered a new technique for measuring TFAs in blood that was used on a subsample of the National Health and Nutrition Examination Survey in 1999–2000 and 2009–2010, allowing the assessment of change in TFA intake over time (15,22).

Types of biological specimens for measuring TFAs

TFAs in the human body are derived from consumption of foods that contain TFAs; they cannot be synthesized by the human body. Therefore, TFA concentrations in human biologic tissues reflect dietary intake (2). Turnover rates or half-lives of fatty acids vary greatly from one part of the human body to another (2,3). Adipose tissue, with a slow turnover (average half-life of approximately 1 or 2 years), can be considered the best choice to assess long-term intake of TFAs. Red blood cells, with a moderate turnover (average half-life of approximately 1–4 months), can be used to assess medium-term intake. Plasma and serum, with a quick turnover (average half-life of approximately 5–10 days), are best used to assess short-term intake. Although adipose tissue might be ideal for assessing long-term intake, in practice, this approach is rarely used in large-scale epidemiologic studies and surveys because of the difficulty in obtaining samples. Specimens of plasma, serum, and red blood cells are widely used because of their accessibility; use of these specimens assumes relatively stable short-term dietary patterns. The standard laboratory protocol developed by CDC can be used to measure TFAs in plasma, serum, and red blood cells (erythrocytes) (22). Whole blood has been proposed as an alternative specimen, and it could yield results on TFA intake that are similar to the results obtained by examining plasma (4). Moreover, the use of whole blood enables microsampling procedures (fingertip prick or heel prick) to collect dried blood-spot samples, which require low blood volume and simplified procedures for handling, storing, and processing samples. Indeed, dried blood-spot samples have been used to test many biomarkers (eg, hemoglobin, vitamin A, HIV) in the Demographic and Health Surveys Program in more than 50 countries (23). However, the dried blood-spot method is not widely used for fatty acid profiling because of its potential limitations (24). Oxidative degradation and filter paper contamination during sample storage and processing may compromise the accuracy of dried blood-spot assays for analyzing fatty acid composition. In addition, lack of consensus in analytic procedures or standard laboratory guidelines and difficulties in measuring fatty acid concentrations in the dried blood-spot samples may affect the reliability and comparability of laboratory data over time and across different populations.

Practice of measuring TFAs in LMICs

Measuring TFAs as a part of national surveys in LMICs could be the most effective and direct way to understand TFA intake. Many LMICs collect blood samples (plasma or serum) as part of their national health or nutrition surveys, so it would be relatively simple to include TFA biomarkers as an additional test. The World Health Organization’s STEPwise Approach to Surveillance uses blood samples to test for cholesterol and blood glucose levels; this simple, standardized method for collecting, analyzing, and disseminating data has been implemented in more than 100 countries (25). National and regional laboratories would need to establish and build the technical and scientific capacity for measuring TFAs in blood and in foods. These laboratory measurements are complex and require a high-quality system to ensure accuracy and reliability of data over time and across countries and regions. High-quality systems would need to include common and standardized measurement protocols, training of personnel, and external quality assessment conducted within a network of laboratories. The data obtained from these laboratories would lead to the establishment of baseline levels of TFA intake, provide scientific evidence of the effect of public health policy making, and help with directing further actions to eliminate iTFAs in the food supply. With surveys and laboratories adhering to the same standards and using the same high-quality system, data can be compared with global references and across countries. Because laboratory measurements of TFAs also enable the measurement of other fatty acids, building laboratory capacity for measuring TFAs and other biomarkers for cardiovascular disease risk factors in blood enables countries and regions to address public health issues beyond iTFA reduction. Improving cardiovascular health through reduction of iTFA intake is feasible through shared experience, technical assistance, and advanced laboratory technology. It can be achieved by collaborating and partnering with key stakeholders in LMICs, and with public and private partners internationally.
CountryAnnual No. of CHD Deaths Due to High Intake of trans Fatty AcidsPercentageCumulative PercentageRanking by No. of CHD Deaths
United States96,61118.1118.111
India63,24311.8629.972
Egypt44,2578.338.273
China42,3567.9446.214
Pakistan40,2397.5453.755
Russia29,4805.5359.286
Mexico18,7323.5162.797
Brazil18,5763.4866.278
Iran14,3982.7068.979
Canada13,9012.6171.5810
Ukraine12,9802.4374.0111
Germany10,9162.0576.0612
Bangladesh8,1371.5377.5913
Indonesia5,7601.0878.6714
Japan5,2710.9979.6615
Poland5,1330.9680.6216
United Kingdom4,7120.8881.5017
Turkey3,9730.7482.2418
Belarus3,5610.6782.9119
Italy3,3810.6383.5420
France3,0840.5884.1221
Philippines3,0670.5784.6922
Netherlands2,8810.5485.2323
Romania2,5910.4985.7224
Uzbekistan2,5350.4886.2025
Thailand2,5170.4786.6726
Iraq2,4750.4687.1327
Colombia2,2150.4287.5528
Nepal2,1780.4187.9629
Sri Lanka2,1620.4188.3730
CountryPolicy
AfghanistanNo or unknown TFA policy
AlbaniaNo or unknown TFA policy
AlgeriaNo or unknown TFA policy
American SamoaNo or unknown TFA policy
AndorraNo or unknown TFA policy
AngolaNo or unknown TFA policy
AnguillaNo or unknown TFA policy
AntarcticaNo or unknown TFA policy
Antigua and BarbudaNo or unknown TFA policy
ArgentinaRestriction of TFAs AND mandatory TFA labeling
ArmeniaRestriction of TFA only
ArubaNo or unknown TFA policy
AustraliaNo or unknown TFA policy
AustriaRestriction of TFA only
AzerbaijanNo or unknown TFA policy
BahamasNo or unknown TFA policy
BahrainMandatory TFA labeling only
BangladeshNo or unknown TFA policy
BarbadosNo or unknown TFA policy
BelarusRestriction of TFA only
BelgiumNo or unknown TFA policy
BelizeNo or unknown TFA policy
BeninNo or unknown TFA policy
BermudaNo or unknown TFA policy
BhutanNo or unknown TFA policy
BoliviaMandatory TFA labeling only
Bonaire, Saint Eustatius, and SabaNo or unknown TFA policy
Bosnia and HerzegovinaNo or unknown TFA policy
BotswanaNo or unknown TFA policy
Bouvet IslandNo or unknown TFA policy
BrazilRestriction of TFAs AND mandatory TFA labeling
British Indian Ocean TerritoryNo or unknown TFA policy
Brunei DarussalamNo or unknown TFA policy
BulgariaNo or unknown TFA policy
Burkina FasoNo or unknown TFA policy
BurundiNo or unknown TFA policy
CambodiaNo or unknown TFA policy
CameroonNo or unknown TFA policy
Cameroon/NigeriaNo or unknown TFA policy
CanadaBanning of PHOs AND mandatory TFA labeling
Cape VerdeNo or unknown TFA policy
Cayman IslandsNo or unknown TFA policy
Central African RepublicNo or unknown TFA policy
ChadNo or unknown TFA policy
ChileRestriction of TFAs AND mandatory TFA labeling
ChinaMandatory TFA labeling only
China/IndiaNo or unknown TFA policy
China/Taiwan, Province of ChinaNo or unknown TFA policy
Christmas IslandNo or unknown TFA policy
Cocos (Keeling) IslandsNo or unknown TFA policy
ColombiaRestriction of TFA only
ComorosNo or unknown TFA policy
CongoNo or unknown TFA policy
Congo, Democratic Republic of theNo or unknown TFA policy
Cook IslandsNo or unknown TFA policy
Costa RicaNo or unknown TFA policy
Cote D'IvoireNo or unknown TFA policy
CroatiaNo or unknown TFA policy
CubaNo or unknown TFA policy
CuracaoNo or unknown TFA policy
CyprusNo or unknown TFA policy
Czech RepublicNo or unknown TFA policy
DenmarkRestriction of TFA only
DjiboutiNo or unknown TFA policy
DominicaNo or unknown TFA policy
Dominican RepublicNo or unknown TFA policy
EcuadorRestriction of TFAs AND mandatory TFA labeling
EgyptNo or unknown TFA policy
El SalvadorNo or unknown TFA policy
Equatorial GuineaNo or unknown TFA policy
EritreaNo or unknown TFA policy
EstoniaNo or unknown TFA policy
EthiopiaNo or unknown TFA policy
Falkland Islands (Malvinas)No or unknown TFA policy
Faroe IslandsNo or unknown TFA policy
FijiNo or unknown TFA policy
FinlandNo or unknown TFA policy
FranceNo or unknown TFA policy
French GuianaNo or unknown TFA policy
French PolynesiaNo or unknown TFA policy
French Southern TerritoriesNo or unknown TFA policy
GabonNo or unknown TFA policy
GambiaNo or unknown TFA policy
GeorgiaNo or unknown TFA policy
GermanyNo or unknown TFA policy
GhanaNo or unknown TFA policy
GibraltarNo or unknown TFA policy
Golan HeightsNo or unknown TFA policy
GreeceNo or unknown TFA policy
GreenlandNo or unknown TFA policy
GrenadaNo or unknown TFA policy
GuadeloupeNo or unknown TFA policy
GuamNo or unknown TFA policy
GuatemalaNo or unknown TFA policy
GuernseyNo or unknown TFA policy
GuineaNo or unknown TFA policy
Guinea-BissauNo or unknown TFA policy
GuyanaNo or unknown TFA policy
HaitiNo or unknown TFA policy
Heard Island and McDonald IslandsNo or unknown TFA policy
Holy See (Vatican City State)No or unknown TFA policy
HondurasNo or unknown TFA policy
HungaryRestriction of TFA only
IcelandRestriction of TFA only
IndiaRestriction of TFAs AND mandatory TFA labeling
IndonesiaNo or unknown TFA policy
Iran, Islamic Republic ofRestriction of TFA only
IraqNo or unknown TFA policy
IrelandNo or unknown TFA policy
Isle of ManNo or unknown TFA policy
IsraelMandatory TFA labeling only
ItalyNo or unknown TFA policy
JamaicaNo or unknown TFA policy
JapanNo or unknown TFA policy
JerseyNo or unknown TFA policy
JordanNo or unknown TFA policy
KazakhstanRestriction of TFA only
KenyaNo or unknown TFA policy
KiribatiNo or unknown TFA policy
Korea, Democratic People's Republic ofNo or unknown TFA policy
Korea, Republic ofMandatory TFA labeling only
KosovoNo or unknown TFA policy
KuwaitMandatory TFA labeling only
KyrgyzstanRestriction of TFA only
Lao People's Democratic RepublicNo or unknown TFA policy
LatviaRestriction of TFA only
LebanonNo or unknown TFA policy
LesothoNo or unknown TFA policy
LiberiaNo or unknown TFA policy
LibyaNo or unknown TFA policy
LiechtensteinNo or unknown TFA policy
LithuaniaRestriction of TFA only
LuxembourgNo or unknown TFA policy
Macedonia, the Former Yugoslav Republic ofNo or unknown TFA policy
MadagascarNo or unknown TFA policy
MalawiNo or unknown TFA policy
MalaysiaNo or unknown TFA policy
MaldivesNo or unknown TFA policy
MaliNo or unknown TFA policy
MaltaNo or unknown TFA policy
Marshall IslandsNo or unknown TFA policy
MartiniqueNo or unknown TFA policy
MauritaniaNo or unknown TFA policy
MauritiusMandatory TFA labeling only
MayotteNo or unknown TFA policy
MexicoNo or unknown TFA policy
Micronesia, Federated States ofNo or unknown TFA policy
Moldova, Republic ofNo or unknown TFA policy
MonacoNo or unknown TFA policy
MongoliaNo or unknown TFA policy
MontenegroNo or unknown TFA policy
MontserratNo or unknown TFA policy
MoroccoNo or unknown TFA policy
MozambiqueNo or unknown TFA policy
MyanmarNo or unknown TFA policy
NamibiaNo or unknown TFA policy
NauruNo or unknown TFA policy
NepalNo or unknown TFA policy
NetherlandsNo or unknown TFA policy
New CaledoniaNo or unknown TFA policy
New ZealandNo or unknown TFA policy
NicaraguaNo or unknown TFA policy
NigerNo or unknown TFA policy
NigeriaNo or unknown TFA policy
NiueNo or unknown TFA policy
Norfolk IslandNo or unknown TFA policy
Northern Mariana IslandsNo or unknown TFA policy
NorwayRestriction of TFA only
OmanNo or unknown TFA policy
PakistanNo or unknown TFA policy
PalauNo or unknown TFA policy
Palestinian Territory, OccupiedNo or unknown TFA policy
PanamaNo or unknown TFA policy
Papua New GuineaNo or unknown TFA policy
ParaguayMandatory TFA labeling only
PeruRestriction of TFAs AND mandatory TFA labeling
PhilippinesMandatory TFA labeling only
PitcairnNo or unknown TFA policy
PolandNo or unknown TFA policy
PortugalNo or unknown TFA policy
Puerto RicoNo or unknown TFA policy
QatarNo or unknown TFA policy
ReunionNo or unknown TFA policy
RomaniaRestriction of TFAs AND mandatory TFA labeling
Russian FederationRestriction of TFA only
RwandaNo or unknown TFA policy
Saint BarthelemyNo or unknown TFA policy
Saint HelenaNo or unknown TFA policy
Saint Kitts and NevisNo or unknown TFA policy
Saint LuciaNo or unknown TFA policy
Saint MartinNo or unknown TFA policy
Saint Pierre and MiquelonNo or unknown TFA policy
Saint Vincent and the GrenadinesNo or unknown TFA policy
SamoaNo or unknown TFA policy
San MarinoNo or unknown TFA policy
Sao Tome and PrincipeNo or unknown TFA policy
Saudi ArabiaRestriction of TFAs AND mandatory TFA labeling
SenegalNo or unknown TFA policy
SerbiaNo or unknown TFA policy
SeychellesNo or unknown TFA policy
Sierra LeoneNo or unknown TFA policy
SingaporeRestriction of TFAs AND mandatory TFA labeling
Sint Maarten (Dutch Part)No or unknown TFA policy
SlovakiaNo or unknown TFA policy
SloveniaRestriction of TFA only
Solomon IslandsNo or unknown TFA policy
SomaliaNo or unknown TFA policy
South AfricaRestriction of TFAs AND mandatory TFA labeling
South Georgia and the South Sandwich IslandsNo or unknown TFA policy
SpainNo or unknown TFA policy
Sri LankaNo or unknown TFA policy
SudanNo or unknown TFA policy
SurinameNo or unknown TFA policy
Suriname/GuyanaNo or unknown TFA policy
Svalbard and Jan MayenNo or unknown TFA policy
SwazilandNo or unknown TFA policy
SwedenRestriction of TFA only
SwitzerlandRestriction of TFA only
Syrian Arab RepublicNo or unknown TFA policy
Taiwan, Province of ChinaNo or unknown TFA policy
TajikistanNo or unknown TFA policy
Tanzania, United Republic ofNo or unknown TFA policy
ThailandRestriction of TFA only
Timor-LesteNo or unknown TFA policy
TogoNo or unknown TFA policy
TokelauNo or unknown TFA policy
TongaNo or unknown TFA policy
Trinidad and TobagoNo or unknown TFA policy
TunisiaNo or unknown TFA policy
TurkeyNo or unknown TFA policy
TurkmenistanNo or unknown TFA policy
Turks and Caicos IslandsNo or unknown TFA policy
TuvaluNo or unknown TFA policy
UgandaNo or unknown TFA policy
UkraineNo or unknown TFA policy
United Arab EmiratesNo or unknown TFA policy
United KingdomNo or unknown TFA policy
United StatesBanning of PHOs AND mandatory TFA labeling
UruguayMandatory TFA labeling only
UzbekistanNo or unknown TFA policy
VanuatuNo or unknown TFA policy
VenezuelaNo or unknown TFA policy
Viet NamNo or unknown TFA policy
Virgin Islands, BritishNo or unknown TFA policy
Virgin Islands, USNo or unknown TFA policy
Wallis and FutunaNo or unknown TFA policy
Western SaharaNo or unknown TFA policy
YemenNo or unknown TFA policy
ZambiaNo or unknown TFA policy
ZimbabweNo or unknown TFA policy
  20 in total

1.  Trans fat and cardiovascular disease mortality: Evidence from bans in restaurants in New York.

Authors:  Brandon J Restrepo; Matthias Rieger
Journal:  J Health Econ       Date:  2015-11-24       Impact factor: 3.883

Review 2.  Trans fatty acids and cardiovascular disease.

Authors:  Dariush Mozaffarian; Martijn B Katan; Alberto Ascherio; Meir J Stampfer; Walter C Willett
Journal:  N Engl J Med       Date:  2006-04-13       Impact factor: 91.245

Review 3.  A trans world journey.

Authors:  Steen Stender; Jørn Dyerberg; Anette Bysted; Torben Leth; Arne Astrup
Journal:  Atheroscler Suppl       Date:  2006-05-19       Impact factor: 3.235

4.  Change in trans fatty acid content of fast-food purchases associated with New York City's restaurant regulation: a pre-post study.

Authors:  Sonia Y Angell; Laura K Cobb; Christine J Curtis; Kevin J Konty; Lynn D Silver
Journal:  Ann Intern Med       Date:  2012-07-17       Impact factor: 25.391

5.  Quantitating fatty acids in dried blood spots on a common collection card versus a novel wicking sampling device.

Authors:  Jan Gunash; Juan J Aristizabal-Henao; Ken D Stark
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2019-05-02       Impact factor: 4.006

6.  Fasting whole blood as a biomarker of essential fatty acid intake in epidemiologic studies: comparison with adipose tissue and plasma.

Authors:  Ana Baylin; Mi Kyung Kim; Amy Donovan-Palmer; Xinia Siles; Lauren Dougherty; Paula Tocco; Hannia Campos
Journal:  Am J Epidemiol       Date:  2005-07-13       Impact factor: 4.897

7.  Impact of a Municipal Policy Restricting Trans Fatty Acid Use in New York City Restaurants on Serum Trans Fatty Acid Levels in Adults.

Authors:  Melecia Wright; Wendy McKelvey; Christine Johnson Curtis; Lorna E Thorpe; Hubert W Vesper; Heather C Kuiper; Sonia Y Angell
Journal:  Am J Public Health       Date:  2019-02-21       Impact factor: 9.308

Review 8.  Biomarkers of fat and fatty acid intake.

Authors:  Lenore Arab
Journal:  J Nutr       Date:  2003-03       Impact factor: 4.798

9.  Quantitation of trans-fatty acids in human blood via isotope dilution-gas chromatography-negative chemical ionization-mass spectrometry.

Authors:  Heather C Kuiper; Na Wei; Samantha L McGunigale; Hubert W Vesper
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2018-01-06       Impact factor: 3.205

10.  Progress towards elimination of trans-fatty acids in foods commonly consumed in four Latin American cities.

Authors:  Rafael Monge-Rojas; Uriyoán Colón-Ramos; Enrique Jacoby; Thelma Alfaro; Maria das Graças Tavares do Carmo; Salvador Villalpando; Claudio Bernal
Journal:  Public Health Nutr       Date:  2017-06-23       Impact factor: 4.022

View more
  9 in total

1.  Dietary Sources of Plasma trans Fatty Acids among Adults in the United States: NHANES 2009-2010.

Authors:  Chaoyang Li; Patricia Richter; Laura K Cobb; Heather C Kuiper; Jennifer Seymour; Hubert W Vesper
Journal:  Curr Dev Nutr       Date:  2021-04-12

2.  Diet Significantly Influences the Immunopathology and Severity of Kidney Injury in Male C57Bl/6J Mice in a Model Dependent Manner.

Authors:  John E Brus; Daniel L Quan; Kristin J Wiley; Brittney Browning; Hannah Ter Haar; Riley Lutz; Jeffrey F Houghton; Joseph C Gigliotti
Journal:  Nutrients       Date:  2021-04-30       Impact factor: 5.717

3.  Performance of HIV detection in Zhejiang province in China: The Pareto principle at work.

Authors:  Jiafeng Zhang; Xiaobei Ding; Xin Zhou; Wanjun Chen; Jiaming Yao; Zhihong Guo; Lin Chen; Yan Xia; Qin Fan
Journal:  J Clin Lab Anal       Date:  2021-05-04       Impact factor: 2.352

4.  Olive Oil Improves While Trans Fatty Acids Further Aggravate the Hypomethylation of LINE-1 Retrotransposon DNA in an Environmental Carcinogen Model.

Authors:  Laszlo Szabo; Richard Molnar; Andras Tomesz; Arpad Deutsch; Richard Darago; Timea Varjas; Zsombor Ritter; Jozsef L Szentpeteri; Kitti Andreidesz; Domokos Mathe; Imre Hegedüs; Attila Sik; Ferenc Budan; Istvan Kiss
Journal:  Nutrients       Date:  2022-02-21       Impact factor: 5.717

5.  Evaluating progress and addressing actions to eliminate industrially produced trans-fatty acids in the Americas.

Authors:  Patiño Sofía Rincón-Gallardo; Steven Constantinou; Carmen Gorlick; Fabio da Silva Gomes
Journal:  Rev Panam Salud Publica       Date:  2022-09-02

6.  Trans Fatty Acids Content in Whole-Day Diets Intended for Pregnant and Breastfeeding Women in Gynaecological and Obstetric Wards: Findings from the Study under the "Mum's Diet" Pilot Program in Poland.

Authors:  Edyta Jasińska-Melon; Hanna Mojska; Beata Przygoda; Katarzyna Stoś
Journal:  Nutrients       Date:  2022-08-16       Impact factor: 6.706

7.  Cost assessment of a program for laboratory testing of plasma trans-fatty acids in Thailand.

Authors:  Biplab Kumar Datta; Wichai Aekplakorn; Anchalee Chittamma; Pornchai Meemeaw; Hubert Vesper; Heather C Kuiper; Lindsay Steele; Laura K Cobb; Chaoyang Li; Muhammad Jami Husain; Lalida Ketgudee; Deliana Kostova; Patricia Richter
Journal:  Public Health Pract (Oxf)       Date:  2021-10-01

8.  ELIMINATION OF INDUSTRIALIZED TRANS-FATTY ACIDS FROM NIGERIAN MEALS - AN URGENT NEED FOR POLICY ADOPTION, IMPLEMENTATION, AND PUBLIC EDUCATION.

Authors:  O F Fagbule
Journal:  Ann Ib Postgrad Med       Date:  2021-12

9.  Analysis of Fat Content with Special Emphasis on Trans Isomers in Frequently Consumed Food Products in Egypt: The First Steps in the Trans Fatty Acid Elimination Roadmap.

Authors:  Ghada Ismail; Randa Abo El Naga; Maysaa El Sayed Zaki; Jana Jabbour; Ayoub Al-Jawaldeh
Journal:  Nutrients       Date:  2021-09-02       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.